What is the definition of alcoholic hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Alcoholic Hepatitis

Alcoholic hepatitis is a clinical syndrome characterized by the rapid onset of jaundice (within 60 days) in patients with heavy alcohol consumption (>50 g/day for ≥6 months), accompanied by serum bilirubin >3 mg/dL, elevated AST (50-400 U/L), AST:ALT ratio >1.5, and exclusion of other causes of hepatitis. 1

Clinical Presentation

Alcoholic hepatitis represents a serious form of acute decompensation of alcoholic liver disease that develops in heavy drinkers and manifests with: 1

  • Rapid onset of jaundice (developing within 60 days of heavy drinking) 1
  • Malaise and anorexia 1
  • Tender hepatomegaly 1
  • Features of systemic inflammatory response syndrome (SIRS) including tachycardia, tachypnea, fever, and leukocytosis 1
  • Potential decompensation with ascites, encephalopathy, bacterial infection, and variceal bleeding 1

Diagnostic Criteria

The NIAAA Alcoholic Hepatitis Consortium established a working definition requiring all of the following elements: 1

Alcohol Consumption Requirements

  • Heavy alcohol use for >6 months with <60 days of abstinence before jaundice onset 1
  • Consumption threshold: >50 g/day (approximately 4 standard drinks) for men, >40 g/day (approximately 3 drinks) for women 1

Laboratory Criteria

  • Serum bilirubin >3 mg/dL (>50 μmol/L) 1
  • AST elevation 50-400 U/L (typically not exceeding 400 U/L, which helps distinguish from drug-induced liver injury or ischemic hepatitis) 1
  • AST:ALT ratio >1.5 (ratios <1.5 occur in <2% of histologically proven cases) 1
  • Exclusion of other causes including viral hepatitis, biliary obstruction, severe autoimmune liver disease, Wilson disease, and drug-induced liver injury 1

Diagnostic Classification System

The NIAAA consensus statement proposed three diagnostic categories to improve research interpretation: 1

  • Definite alcoholic hepatitis: Diagnosis established by liver biopsy 1
  • Probable alcoholic hepatitis: Clinical and laboratory features present without confounding problems 1
  • Possible alcoholic hepatitis: Clinical features present but with confounding problems 1

Histologic Features

When liver biopsy is performed, characteristic findings include: 1

  • Macrovesicular steatosis 1
  • Ballooning degeneration of hepatocytes (steatohepatitis) 1
  • Neutrophil infiltration 1
  • Mallory-Denk bodies 1
  • Intrahepatic cholestasis (bilirubinostasis) 1
  • Chicken-wire fibrosis 1
  • Megamitochondria 1
  • Cirrhosis (present in the vast majority of severely ill patients) 1

Clinical Significance and Prognosis

Severe alcoholic hepatitis carries a high short-term mortality rate of 40-50% if untreated, making accurate diagnosis critical for guiding therapy. 1, 2 The condition is associated with: 1

  • High risk of nutritional deficiency 1
  • Infection (common and must be identified) 1
  • Acute kidney injury (AKI) 1
  • Development of multiorgan failure (MOF) syndrome 1

Important Diagnostic Caveats

Liver biopsy reveals that 10-20% of patients with a clinical diagnosis of alcoholic hepatitis may have other liver diseases or may not have histologic alcoholic steatohepatitis, underscoring the value of biopsy when feasible. 1 However, the diagnosis is primarily clinical in most cases, with biopsy reserved for uncertain situations or research purposes. 1

The distinction between alcoholic hepatitis and nonalcoholic steatohepatitis (NASH) can be challenging, as elevated BMI is a risk factor for both conditions; differentiation typically relies on the amount of alcohol consumed and the rapid onset of jaundice. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.